Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis

Dermatol Online J. 2019 Jun 15;25(6):13030/qt89b75552.

Abstract

Gottron papules, a heliotrope rash, scalp and extremity erythema, pruritus, and fatigue are the characteristic signs and symptoms of amyopathic dermatomyositis (ADM). Amyopathic dermatomyositis is considered a distinct entity from dermatomyositis (DM) because the characteristic muscle weakness and muscle enzyme elevations of DM are absent in ADM. With respects to treatment, ADM treatments have traditionally included topical corticosteroids and/or systemic immunosuppressants and immunomodulators. Herein we present a patient with refractory ADM that was responsive to low-dose naltrexone therapy.

Publication types

  • Case Reports

MeSH terms

  • Dermatomyositis / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Naltrexone / administration & dosage*
  • Naltrexone / therapeutic use
  • Narcotic Antagonists / administration & dosage*
  • Narcotic Antagonists / therapeutic use

Substances

  • Narcotic Antagonists
  • Naltrexone

Supplementary concepts

  • Amyopathic dermatomyositis